Market
What will be the first significant breakthrough in AI-driven cancer treatment attributed to the Stargate Project by 2026?
2
Oracle•Larry Ellison•White House•Ellison•Stargate Project•OpenAI•SoftBank•Masayoshi Son•Sam Altman•United States•Texas
Resolution / Starting Odds
Early detection accuracy improvement • 25%
Personalized vaccine development • 25%
Treatment cost reduction • 25%
Other • 25%
Scientific publications or announcements from Oracle or major healthcare organizations
Story
Oracle's Larry Ellison Unveils $500 Billion AI-Driven Cancer Vaccine Initiative
Jan 22, 2025, 02:20 AM
Oracle CEO Larry Ellison announced at a White House event that artificial intelligence (AI) will revolutionize cancer treatment by enabling early detection and the rapid development of personalized mRNA vaccines. Ellison explained that AI can detect cancer through blood tests, gene sequence tumors, and design vaccines tailored to individual patients. These vaccines can be produced robotically within 48 hours. The announcement was part of discussions surrounding the Stargate Project, a $500 billion initiative involving Oracle, OpenAI, and SoftBank to build AI-powered data centers. The project, which includes contributions from SoftBank CEO Masayoshi Son and OpenAI CEO Sam Altman, aims to enhance healthcare innovation and create over 100,000 jobs in the United States. The first data centers are already under construction in Texas.
View original story
Similar markets
Healthcare • 25%
Finance • 25%
Automotive • 25%
Retail • 25%
Breakthrough Prize • 25%
Lasker Award • 25%
No major award • 25%
Nobel Prize • 25%
Oracle • 25%
SoftBank • 25%
OpenAI • 25%
Other • 25%
Phase 1 Clinical Trials • 25%
No further development • 25%
Partnership with NGO • 25%
Licensing Agreement • 25%
NVIDIA • 25%
OpenAI • 25%
Other • 25%
Oracle • 25%
Technology • 25%
Other • 25%
Construction • 25%
Manufacturing • 25%
Computer Vision • 25%
Other • 25%
Natural Language Processing • 25%
Autonomous Systems • 25%
Cleveland Clinic • 25%
Johns Hopkins • 25%
Mayo Clinic • 25%
Other • 25%